Pierre Fabre supports patient choice
The relentless pressure on the NHS is felt not just in balance sheets but at the frontline of care. By moving chemotherapy out of the hospital, Pierre Fabre can help both patients and the NHS
- UCL study to assess link between navigation and AD using virtual reality
- New heart disease calculator more accurately predicts patients’ risk of CVDs
- Trial reveals mechanisms that contribute to impact of malnutrition and HIV infection
- Boehringer Ingelheim and Ochre Bio partner on liver disease in deal worth over $1bn
- New NIHR HRC launched for cardiovascular and respiratory medicine
